Who are unsuitable for using anti-aging peptides?

Jan 19, 2026

Leave a message

The main groups unsuitable for using anti-aging peptides include: pregnant and breastfeeding women, people with severe allergies, those with impaired liver or kidney function, patients with autoimmune diseases, minors, and patients with certain chronic diseases. These individuals should use them with caution or avoid them altogether.

 

Your concern about this issue shows you have a rational understanding of health and anti-aging methods, which is commendable. While pursuing a youthful appearance, safety should always be the top priority. The following is a list of groups who should not use or need to use with caution, compiled based on available information, for your reference:

 

Groups explicitly advised against use:

Pregnant and breastfeeding women: Current research on the effects of peptide supplements on fetuses or infants is insufficient, and potential risks exist. To ensure maternal and infant safety, it is recommended to avoid using any form of anti-aging peptide products (especially oral ones) during pregnancy and breastfeeding.

 

Those with severe liver or kidney dysfunction: The metabolism of peptides in the body produces nitrogenous waste, which is mainly detoxified by the liver and excreted by the kidneys. Individuals with impaired liver or kidney function have reduced metabolic capacity; consuming peptides may further burden these organs, potentially leading to liver damage or further deterioration of kidney function.


Those allergic to proteins or peptides: Collagen peptides are essentially protein hydrolysis products, and some individuals may be allergic to their components, experiencing reactions such as rashes, itching, redness, swelling, and difficulty breathing. In severe cases, this can lead to anaphylactic shock. Individuals with a history of allergies should undergo a skin test first or use the product under the guidance of a doctor.


Patients with autoimmune diseases: Such as rheumatoid arthritis and systemic lupus erythematosus, patients may experience a risk of triggering or worsening their condition due to the potential impact of peptides on the immune system. Their use should be determined after evaluation by a professional physician.